Date published: 2026-4-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

LT-β Activators

LT-β activators are a specialized group of chemical entities that target and modulate the activity of the protein lymphotoxin-beta (LT-β), which is part of the tumor necrosis factor (TNF) superfamily and plays a role in the organization of lymphoid tissue, the development of secondary lymphoid organs, and the regulation of immune responses. LT-β forms a heterotrimeric complex with lymphotoxin-alpha (LT-α) to interact with the LT-β receptor (LTβR), triggering a cascade of intracellular events that can influence inflammation and immune system architecture. The mechanisms through which LT-β activators function can manifest in several ways: direct activators may bind to LT-β itself, inducing a conformational change that enhances its affinity or efficacy in interacting with LTβR. This could amplify the downstream signaling pathways that are normally engaged upon LT-β/LTβR interaction.

Indirect activators may influence the expression levels of LT-β or LTβR, modulate the processing or maturation of these proteins, or alter the signaling environment in a manner that affects their interaction or the downstream signaling cascade. The study of LT-β activators is mainly focused on delineating the complex signaling pathways and understanding the role of LT-β in the immune system, which is of significant interest in the field of immunology research. By probing the function and regulation of LT-β through chemical activators, researchers can gain deeper insights into how immune responses and lymphoid tissue development are orchestrated at the molecular level.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin is an activator of adenylate cyclase, enhancing intracellular cyclic AMP levels. cAMP can activate protein kinase A, which can phosphorylate and activate LT-β, leading to increased activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-specific inhibitor of PDE, which enhances cAMP and cGMP levels. This could activate LT-β through the protein kinase A pathway.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$126.00
$328.00
30
(1)

As a cAMP analog, 8-Bromo-cAMP activates PKA and may thereby increase LT-β activity.

Sodium nitroprusside dihydrate

13755-38-9sc-203395
sc-203395A
sc-203395B
1 g
5 g
100 g
$43.00
$85.00
$158.00
7
(1)

Sodium Nitroprusside stimulates guanylate cyclase, promoting cGMP production. This can activate LT-β through the protein kinase G pathway.

Sp-cAMPS

93602-66-5sc-201571
1 mg
$97.00
3
(1)

Sp-cAMPS is a cell-permeable cAMP analog that activates PKA, potentially increasing LT-β activity.

8-Bromo-cGMP

51116-01-9sc-200316
sc-200316A
10 mg
50 mg
$104.00
$354.00
7
(1)

As a cell-permeable cGMP analog, 8-Br-cGMP can activate protein kinase G, potentially enhancing LT-β activity.

Cilostamide (OPC 3689)

68550-75-4sc-201180
sc-201180A
5 mg
25 mg
$92.00
$357.00
16
(1)

Cilostamide inhibits PDE3, leading to increased levels of cAMP, which can activate PKA and potentially enhance LT-β activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram is a selective inhibitor of PDE4, increasing cAMP levels, which could activate PKA and enhance LT-β activity.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

Milrinone is a PDE3 inhibitor that increases cAMP levels, potentially activating PKA and enhancing LT-β activity.